Provectus expands compassionate use for PV-10 - - ModernMedicine

Provectus expands compassionate use for PV-10
Publish date: Nov 3, 2009
By:  Allison Tsai
Source: Dermatology Times E-News

National report — Provectus Pharmaceuticals has expanded its compassionate use program for PV-10, which is being developed as a therapeutic agent for metastatic melanoma and other cancers, making it available for select cancer patients in the United States, according to a press release.

The program, being implemented under the U.S. Food and Drug Administration (FDA) guidelines covering compassionate use of an investigational new drug, began at St. Luke’s Hospital & Health Network in Bethlehem, Pa. Provectus recently announced that all patients in the phase 2 clinical trial for metastatic melanoma had been treated, according to the press release.

The program was initiated in Australia in June 2009. Both the U.S. program and the Australian program make PV-10 available only for cancer indications that do not involve visceral organs. Available indications include certain breast cancers, basal cell carcinoma, squamous cell carcinoma, certain head and neck cancers and melanoma.

Provectus plans to expand the compassionate use program to other U.S. sites in the coming months.
post a comment
Please complete the form below to post your comment.
Bold = Required
Email Address Your email address will NOT be published.
Display Name appears with your comment
City
State
Country
Remember me: YesNo
Comment read our privacy policy
Note: does not support HTML
All comments submitted are subject to review and may be delayed before posting. We reserve the right not to post comments. Comments from patients or members of patients' families seeking medical advice will not be posted.
eSamples check closet
eSamples check closet
Featured Jobs

More Jobs

Practice ToolsPractice Tools
Coding Counselor
Coding Counselor

Simple and accurate ICD-9 code search. Start Here

Patient Education
Patient Education

Print customized patient education handouts. Start Here

Dermatology Diagnosis
Dermatology Diagnosis

Identify skin diseases by age, gender, location. Start Here

AHRQ Clinical Guidelines
AHRQ Clinical Guidelines

Objective findings on medical interventions. Start Here

Clinical Perspectives
AcneAdolescent MedicineAllergy & ImmunologyAlzheimer's DiseaseAsthmaBPHBreast CancerCardiologyCataractsChild Behavior & DevelopmentClinical PharmacologyContraceptionCorneal DiseaseCosmetic DermatologyCosmetic SurgeryDepressionDermatologyDiabetesDry EyeEczema/Atopic DermatitisEndocrinologyEpilepsyErectile DysfunctionGastroenterologyGastroesophageal Reflux Disease (GERD) & Acid Peptic DiseaseGeriatricsGlaucomaGynecologic OncologyHIV/AIDSHormone TherapyHyperlipidemiaHypertensionImmunization/VaccinesInfectious DiseaseInternal MedicineIrritable Bowel Syndrome (IBS)Kidney & Bladder CancerLaser & Light Technology in DermatologyMaternal & Fetal MedicineMenopauseMigraineMultiple SclerosisNeurologyNutritionOb/Gyn SurgeryObesityOB/GYN & Women's HealthOncologyOphthalmologyOptometryOrthopedicsOsteoporosisParkinson's DiseasePathologyPediatrics Primary Care MedicineProstate CancerPsoriasisPsychiatry & Behavioral HealthRadiologyRefractive SurgeryReproductive Endocrinology/InfertilityRetinal DiseaseRheumatoid ArthritisSkin CancerSleep DisordersSmoking-Related IllnessStrokeSurgeryUrinary Incontinence/Overactive BladderUrologic SurgeryUrology
Business Perspectives
Coding CounselorLiability & Risk ManagementHealth Care Information TechnologyPractice ManagementBusiness OperationsHuman ResourcesHealth Law & PolicyManaged CarePersonal FinanceProducts
Popular Topics
CME/CECoding CounselorEczema: Emollients, Counseling, and CareFind Resources to Help Manage Plaque Psoriasis Effectively [SPONSORED]Oral Anticoagulation in Atrial FibrillationEHR Technology eNewslettersGERD Resources for Your Practice and Patients [SPONSORED]Find Resources to Help Inform Patients on Managing Their IOP [SPONSORED]Find Resources to Help with Cataract Procedures [SPONSORED]Learn about Wavefront Technology in Progressive Lenses [SPONSORED]Help Prevent SREs in Your Patients with Bone Metastases [SPONSORED]Rx Adherence ToolAHA 2010 Video ReportsSurgery as Early Intervention in Morbid ObesityPatient Education CenterFracture Risk in Postmenopausal WomenBlogsSpecial Reports from The National Center for Children in Poverty (NCCP) DiscussionsModernMedicine RadioClinical Reference ManualsSyndicationSurgical Video Center


Source: Dermatology Times E-News, 11/3/2009
Click here